Published Online
on November 29, 2007

A more recent version of this article appeared on January 1, 2008

This Article Full Text (PDF) All Versions of this Article: 39/1/7    most recent STROKEAHA.107.496554v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lane, D. A. Articles by Lip, G. Y.H. Search for Related Content PubMed PubMed Citation Articles by Lane, D. A. Articles by Lip, G. Y.H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Stroke Hazardous Substances DB WARFARIN Related Collections Anticoagulants Related Article

Barriers to Anticoagulation in Patients With Atrial Fibrillation. Changing Physician-Related Factors

Deirdre A. Lane PhD and Gregory Y.H. Lip MD, FRCPE^*

From the Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England.

^* To whom correspondence should be addressed. E-mail: g.y.h.lip{at}bham.ac.uk.

Key words: anticoagulation • antithrombotics • atrial fibrillation

Related Article:

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians

Melina Gattellari, John Worthington, Nicholas Zwar, and Sandy Middleton
Stroke 2008 39: 227-230. [Abstract] [Full Text] [PDF]